176 related articles for article (PubMed ID: 31862274)
21. Potassium channel openers as potential therapeutic weapons in ion channel disease.
Lawson K
Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
[TBL] [Abstract][Full Text] [Related]
22. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Judge SI; Smith PJ; Stewart PE; Bever CT
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
[TBL] [Abstract][Full Text] [Related]
23. Brain mitochondrial ATP-insensitive large conductance Ca⁺²-activated K⁺ channel properties are altered in a rat model of amyloid-β neurotoxicity.
Jafari A; Noursadeghi E; Khodagholi F; Saghiri R; Sauve R; Aliaghaei A; Eliassi A
Exp Neurol; 2015 Jul; 269():8-16. PubMed ID: 25828534
[TBL] [Abstract][Full Text] [Related]
24. Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.
Qiu Q; Yang M; Gong D; Liang H; Chen T
Neural Regen Res; 2024 Jun; ():. PubMed ID: 38845230
[TBL] [Abstract][Full Text] [Related]
25. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
26. Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease.
Chen X; Xue B; Wang J; Liu H; Shi L; Xie J
Neurosci Bull; 2018 Apr; 34(2):341-348. PubMed ID: 28884460
[TBL] [Abstract][Full Text] [Related]
27. Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.
Zhang X; Wan JQ; Tong XP
CNS Neurosci Ther; 2018 Apr; 24(4):311-318. PubMed ID: 29377621
[TBL] [Abstract][Full Text] [Related]
28. Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons.
Murakoshi H; Trimmer JS
J Neurosci; 1999 Mar; 19(5):1728-35. PubMed ID: 10024359
[TBL] [Abstract][Full Text] [Related]
29. L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases.
Yagami T; Kohma H; Yamamoto Y
Curr Med Chem; 2012; 19(28):4816-27. PubMed ID: 22834820
[TBL] [Abstract][Full Text] [Related]
30. Molecular physiology of neuronal K-ATP channels (review).
Liss B; Roeper J
Mol Membr Biol; 2001; 18(2):117-27. PubMed ID: 11463204
[TBL] [Abstract][Full Text] [Related]
31. Homeostatic regulation of neuronal excitability by K(+) channels in normal and diseased brains.
Misonou H
Neuroscientist; 2010 Feb; 16(1):51-64. PubMed ID: 20236949
[TBL] [Abstract][Full Text] [Related]
32. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
33. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
Pan Y; Xu X; Tong X; Wang X
J Neurosci Res; 2004 Jul; 77(1):94-9. PubMed ID: 15197742
[TBL] [Abstract][Full Text] [Related]
34. [Memory and potassium channels].
Solntseva EI; Bukanova IuV; Skrebitskiĭ VG
Usp Fiziol Nauk; 2003; 34(4):16-25. PubMed ID: 14658300
[TBL] [Abstract][Full Text] [Related]
35. BK-Type K(Ca) channels in two parasympathetic cell types: differences in kinetic properties and developmental expression.
Cameron JS; Dryer SE
J Neurophysiol; 2000 Dec; 84(6):2767-76. PubMed ID: 11110807
[TBL] [Abstract][Full Text] [Related]
36. Is there a role for potassium channel openers in neuronal ion channel disorders?
Lawson K
Expert Opin Investig Drugs; 2000 Oct; 9(10):2269-80. PubMed ID: 11060806
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death.
Mattson MP; Liu D
Biochem Biophys Res Commun; 2003 May; 304(3):539-49. PubMed ID: 12729589
[TBL] [Abstract][Full Text] [Related]
38. Diversity of astrocyte potassium channels: An update.
Seifert G; Henneberger C; Steinhäuser C
Brain Res Bull; 2018 Jan; 136():26-36. PubMed ID: 27965079
[TBL] [Abstract][Full Text] [Related]
39. Structure and function of Kv4-family transient potassium channels.
Birnbaum SG; Varga AW; Yuan LL; Anderson AE; Sweatt JD; Schrader LA
Physiol Rev; 2004 Jul; 84(3):803-33. PubMed ID: 15269337
[TBL] [Abstract][Full Text] [Related]
40. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
